Phase III Data And GMP Nod Bring Prestige’s Trastuzumab Closer To Launch

Latest Developments Bode Well For Tuznue Biosimilar Rival To Herceptin

 
• By Dave Wallace
  
Double Six Red Dice Good Luck
Two positive developments will allow Prestige to move forward • Source: Stocksolutions / Alamy Stock Photo

More from Biosimilars

More from Products